MedPath

Sudden Death Stratification

Completed
Conditions
Non-ischemic Cardiomyopathy
Interventions
Diagnostic Test: Cardiac MRI
Registration Number
NCT04607265
Lead Sponsor
Hospices Civils de Lyon
Brief Summary

Sudden cardiac death (SCD) risk stratification is a challenge in non-ischemic cardiomyopathy (NICM). The underlying mechanism of monomorphic ventricular tachycardia (VT) is mostly scar related. While electrophysiological mechanisms underlying ventricular arrhythmia are well known, late gadolinium enhanced (LGE) cardiac MRI-3D reconstructions are now able to guide VT ablation procedures. Such exam may help in identifying specific properties of scar at risk of malignant arrhythmia.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
30
Inclusion Criteria
  • Adult with NICM
  • Previous history of ventricular tachycardia (VT) and no previous history of VT
Read More
Exclusion Criteria
  • Inherited cardiomyopathies
  • Previous history of myocarditis WITHOUT oedema/scar at the MRI
Read More

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Ventricular tachycardia (VT) groupCardiac MRINICM patients admitted for a VT ablation with a pre-operative cardiac- MRI.
Control groupCardiac MRINICM patients without ventricular arrhythmia and a previous cardiac-MRI. The matching with the VT group was based on the age of the patients, the mean LVEF, the time between the initial diagnosis and the MRI examination, and the origin of the NICM.
Primary Outcome Measures
NameTimeMethod
Detect pro arrhythmogenic scar characteristicsbaseline : collected at the time of the cardiac MRI

The outcomes will aim to provide scar characteristics from 3D cardiac MRI reconstructions to detect pro arrhythmic properties in NICM patients. Comparisons between NICM patients who experienced VT ablation and NICM patients without history of ventricular arrhythmia will be made.

In both groups, Primary outcome will aim to measure the number of the conducting channels into scars (n).

Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath